Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes (Q46498390)
Jump to navigation
Jump to search
scientific article published in April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes |
scientific article published in April 2005 |
Statements
1 reference
Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes (English)
1 reference
Mitsushige Sugimoto
1 reference
Takahisa Furuta
1 reference
Naohito Shirai
1 reference
Akiko Nakamura
1 reference
Masayoshi Kajimura
1 reference
Akira Hishida
1 reference
Kyoichi Ohashi
1 reference
Takashi Ishizaki
1 reference
1 April 2005
1 reference
77
1 reference
4
1 reference
302-311
1 reference